You searched for "regeneration"
Hypothyroidsim and acute central serous chorioretinopathy – is there a link?
This cross-sectional study included 71 consecutive acute central serous chorioretinopathy (CSC) patients and 70 age-matched healthy control subjects. Systemic findings, including serum levels of thyroid hormones, thyroid stimulating hormone (TSH), mean arterial pressure (MAP), pulse rate, serum lipid levels and...
Atropine treatment for myopia in western countries – rationale
This preliminary study sets out the rationale, methodology and participant baseline characteristics for the Western Australia Atropine for the Treatment of Myopia (WA-ATOM). It is a double masked randomised placebo-controlled trial. This study is designed to be combined with the...Team Arunodaya is happy to announce their August rewards!
Team Arunodaya is happy to announce that in the month of August, 2024, their doctors received the following prestigious awards.Haag-Streit UK look forward to exhibiting at 100% Ophthalmology 2024
Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is pleased to announce it will be exhibiting at 100% Ophthalmology in February 2024.Melton optometrist and lecturer wins RNIB Eye Care Professional of the Year Award
The RNIB See Differently Awards, supported by People’s Postcode Lottery, recognise and celebrate outstanding work supporting people with sight loss. Hosted by standup comedian, Jamie MacDonald, the awards took place on Tuesday 21 May.Improving eye care for children with learning difficulties: a view from SeeAbility
Marek P Karas from sightloss charity SeeAbility examines why children with a learning disability do not access the eye care they need and asks how the system needs to change. Children with a learning disability are 28 times more likely...Effective treatment for rare sight-threatening infection
A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.
